BioVentrix Continues Battle To Remodel Post-Attack Hearts

 
• By Barnaby Pickering

Following reimbursement approval in Germany, BioVentrix is making headway in long-neglected post-heart attack treatments.

Transcatheter Device
BioVentrix's Revivent TC • Source: BioVentrix, Inc.

More from Policy & Regulation

More from Medtech Insight